PharmaVoice 9. März 2026 The first KRAS drugs have been sluggish on the market. Will the next generation fare better?
PharmaVoice 4. März 2026 Inside the race to thwart the dramatic rise in early-onset colorectal cancer
PharmaVoice 3. März 2026 J&J’s blockbuster Spravato is setting the stage for managing psychedelics’ risks
PharmaVoice 19. Feb. 2026 Will vaccine regulatory uncertainty chill innovation? Pharma execs sound off.